Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.37B
• 1 day: 2.95%
• 5 days: 6.35%
• 1 month: 3.81%
• 3 months: 48.82%
• 6 months: 56.03%
• Year to date: -10.71%
• 1 year: -18.92%
• 5 years: 220.54%
• 10 years: 87.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437